+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of human T lymphocyte surface antigen mobility by purinergic receptors

Journal of Immunology 133(6): 3298-3302
Regulation of human T lymphocyte surface antigen mobility by purinergic receptors
The present study was undertaken to establish whether the capping mechanism of normal human T lymphocytes is regulated by a purinergic receptor. Interaction of T lymphocytes with adenosine significantly increased the mobility of the T3, T4, and T8 surface antigens. This enhanced rate of capping was reflected by a significant decrement in the time intervals to achieve half-maximal capping. T lymphocytes preincubated with theophylline or isobutylmethylxanthine did not exhibit accelerated capping or a decrease in the time required for half-maximal capping in response to adenosine, suggesting that these agents inhibited the binding of adenosine to its receptor. A role for a cAMP-dependent pathway in capping was suggested by the observation that the phosphodiesterase inhibitor RO-201724 caused a decrease in the concentration of adenosine required to accelerate the capping process. Moreover, exposure of T lymphocytes to the cyclic nucleotide derivatives 8-N3-cAMP and 8-Br-cAMP mimicked the effect of adenosine, significantly reducing the time to half-maximal capping. Photoaffinity labeling of intracellular cAMP receptors with 32P-8-N3-cAMP indicated that adenosine caused occupancy of the receptors. This effect of adenosine was inhibited by theophylline, a known purinergic receptor blocker. The data support the concept that the T cell capping mechanism is mediated by an adenylate cyclase-coupled purinergic receptor that activates a cAMP-dependent pathway, and that this pathway is functional in the T3+, T4+, (inducer) and T3+, T8+ (suppressor) subsets.

Accession: 006288590

PMID: 6092471

Related references

Regulation of human t lymphocyte surface antigen mobility by a cyclic amp dependent pathway. Federation Proceedings 44(4): 1300, 1985

Purinergic receptors mediated memory of exposure to extracellular ligands in regulation of antigen-driven, T-lymphocyte dependent immune response. Drug Development Research 43(1): 40, Jan, 1998

Mobility of the human T lymphocyte surface molecules CD3, CD4, and CD8: regulation by a cAMP-dependent pathway. Proceedings of the National Academy of Sciences of the United States of America 85(3): 792-796, 1988

Mobility of the human t lymphocyte surface molecules cd3 cd4 and cd8 regulation by a cyclic amp dependent pathway. Proceedings of the National Academy of Sciences of the United States of America 85(3): 792-796, 1988

Studies of human lymphocyte surface antigens ii. a monoclonal antibody against a 50 kilodalton human t lymphocyte surface antigen. Zhonghua Weishengwuxue He Mianyixue Zazhi 6(2): 65-70, 1986

The effects of concanavalin A on the mobility of lymphocyte surface receptors. Experimental Cell Research 81(1): 143-155, 1973

The functional significance distribution and structure of lymphocyte function associated antigen 1 lymphocyte function associated antigen 2 and lymphocyte function associated antigen 3 cell surface antigens associated with cytolytic t lymphocyte target interactions. Journal of Immunology 131(2): 611-616, 1983

Down regulation of b lymphocyte function by cooperative interaction between fc receptors and antigen receptors. Federation Proceedings 45(3): 713, 1986

The mobility and self-associations of MHC receptors at the cell surface of antigen presenting cells. Human Immunology 47(1-2): 93, 1996

Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines. Cancer Research 39(3): 956-958, 1979